Radiation safety company Mirion (NYSE:MIR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.9% year on year to $223.1 million. Its non-GAAP profit of $0.12 per share was 17.1% ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028556015/en/ The articles, information, and content displayed on this webpage ...
Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, has ...
Partnership Agreement to Strengthen Radiation Detection and Measurement Capabilities at the Terrestrial Environmental Radiochemistry (TERC) Laboratory, Safeguarding the Environment and Promoting ...
Mirion was awarded an approximately $10 million small modular reactor new build order in the third quarter 2025. Subsequently, in October 2025, Mirion was awarded an approximately $55 million order ...
"Mirion posted another strong quarter supported by the continued momentum in the nuclear power end-market," commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. "All key financial ...
244,370,206 shares of Class A common stock were outstanding as of September 30, 2025. This excludes (1) 5,979,555 shares of Class B common stock outstanding as of September 30, 2025, (2) 1,291,937 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback